ABBV
AbbVie, Inc. · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website abbvie.com
- Employees(FY) 50000
- ISIN US00287Y1091
Performance
+3.75%
1W
+2.39%
1M
-5.34%
3M
+22.66%
6M
+9.45%
YTD
+20.83%
1Y
Profile
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; California Institute for Biomedical Research (Calibr), and BigHat Biosciences, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Investment Analysis Report: ABBV
Overview:
AbbVie Inc. (ABBV) operates in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $314.59 billion. In this report, we will conduct a detailed analysis of ABBV's financial health, valuation, earnings and revenue growth, profitabil...
Technical Analysis of ABBV 2024-05-10
Overview:
In analyzing the technical indicators for ABBV over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...
Recent News & Updates
- 2024-05-08 09:37
- 2024-05-08 08:32
- 2024-05-08 02:50
15 Best S&P 500 Dividend Stocks To Buy Now(Insidermonkey)
- 2024-05-08 02:04
- 2024-05-07 22:24
- 2024-05-07 20:00
- 2024-05-07 16:30
- 2024-05-07 14:50
15 Best S&P 500 Dividend Stocks To Buy Now(Insider Monkey)
- 2024-05-07 14:04
- 2024-05-07 02:30
3 Biotech Stocks to Double Your Money in the Next 24 Months(Investorplace)
- 2024-05-06 20:38
10 Best May Dividend Stocks To Buy(Insidermonkey)
- 2024-05-06 09:10
- 2024-05-06 08:38
10 Best May Dividend Stocks To Buy(Insider Monkey)
- 2024-05-06 08:00
- 2024-05-05 20:00
- 2024-05-05 13:44
3 Reasons to Buy AbbVie Stock on the Dip(Motley Fool)
- 2024-05-04 01:01
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight(GuruFocus.com)
- 2024-05-04 00:38
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript(Insidermonkey)
- 2024-05-03 11:29
- 2024-05-03 09:40
- 2024-05-03 00:11
Top 25 Stocks in the S&P 500 by Index Weight Right Now(Yahoo Finance)
- 2024-05-02 03:01
The top pharmaceutical companies by R&D expenditure(Pharmaceutical Technology)
- 2024-05-02 01:46
- 2024-05-01 21:00
- 2024-05-01 13:46
- 2024-05-01 09:00
- 2024-05-01 09:00
- 2024-05-01 01:50
- 2024-05-01 00:02
Trials to watch: Four ALS drugs to keep an eye on(Yahoo Finance)
- 2024-04-30 23:45